These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17638958)

  • 21. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing the dose of diuretics for heart failure patients: how low can it go?
    Oshima K; Kohsaka S; Koide K; Yoshikawa T
    Cardiology; 2009; 114(2):89. PubMed ID: 19420935
    [No Abstract]   [Full Text] [Related]  

  • 23. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease.
    Singer AJ; Emerman C; Char DM; Heywood JT; Kirk JD; Hollander JE; Summers R; Lee CC; Wynne J; Kellerman L; Peacock WF
    Ann Emerg Med; 2008 Jan; 51(1):25-34. PubMed ID: 17949853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levosimendan in acute decompensation of anthracycline-induced cardiotoxicity.
    Garcia JA; Simvoulidis LF; Salluh JI; Hansen MH; Feres GA; Holanda GS; Souza RC; Toscano L; Soares M
    Int J Cardiol; 2007 Jun; 118(3):406-7. PubMed ID: 17028018
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intravenous nitroglycerin infusion in patients with acute heart failure].
    Svensson G; Strandberg LE; Erhardt L
    Lakartidningen; 1986 Apr; 83(14):1282-4. PubMed ID: 3084893
    [No Abstract]   [Full Text] [Related]  

  • 27. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMET challenges paradigm of ACE inhibition in mild heart failure.
    Cardiovasc J S Afr; 2003; 14(4):207-8. PubMed ID: 14619868
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta blockade in diabetic heart failure.
    Lukas MA
    Heart Fail Clin; 2006 Jan; 2(1):89-99. PubMed ID: 17386880
    [No Abstract]   [Full Text] [Related]  

  • 30. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
    Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
    Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intravenous molsidomine administration in heart failure. Part I: Dose-response relationship with reference to hemodynamic parameters].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():47-9. PubMed ID: 7968903
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacotherapy of acute and chronic heart failure: part 2.
    Lindenfeld J
    Curr Heart Fail Rep; 2009 Mar; 6(1):3-4. PubMed ID: 19278050
    [No Abstract]   [Full Text] [Related]  

  • 34. New Insights Into Tolvaptan Treatment and the Renin-Angiotensin-Aldosterone System.
    Kida K
    Int Heart J; 2017 May; 58(3):307-309. PubMed ID: 28539577
    [No Abstract]   [Full Text] [Related]  

  • 35. Could risk stratification aid the treatment of patients with acute decompensated heart failure?
    Krum H
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):334-5. PubMed ID: 16265554
    [No Abstract]   [Full Text] [Related]  

  • 36. Coenzyme Q(10) and congestive heart failure: what is the verdict?
    Raj SR; Weisel RD; Verma S
    Can J Cardiol; 2002 Oct; 18(10):1054-8. PubMed ID: 12420040
    [No Abstract]   [Full Text] [Related]  

  • 37. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
    Thomas KL; Al-Khatib SM; Lokhnygina Y; Solomon SD; Kober L; McMurray JJ; Califf RM; Velazquez EJ
    Am Heart J; 2008 Jan; 155(1):87-93. PubMed ID: 18082495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose systemic corticosteroids may be effective early in the course of bronchiolitis.
    Weinberger MM
    Pediatrics; 2007 Apr; 119(4):864-5; discussion 865-6. PubMed ID: 17403865
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.
    Udelson JE; Orlandi C; Ouyang J; Krasa H; Zimmer CA; Frivold G; Haught WH; Meymandi S; Macarie C; Raef D; Wedge P; Konstam MA; Gheorghiade M
    J Am Coll Cardiol; 2008 Nov; 52(19):1540-5. PubMed ID: 19007589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.